The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.

Erkan TopkanUgur Selek Berrin PehlivanAhmet KucukDuriye OzturkBeyza Sirin OzdemirAli Ayberk BesenHuseyin Mertsoylu

Published in: Cancers (2023)

The newly developed GINI index efficiently divided the stage IIIC NSCLSC patients into two subgroups with substantially different median and long-term survival outcomes.

Keyphrases

end stage renal disease
locally advanced
newly diagnosed
physical activity
rectal cancer
peritoneal dialysis
squamous cell carcinoma
radiation therapy